Why Inhibikase Therapeutics (IKT) Stock Is Up 50% Today – Inhibikase Therapeutics
Inhibikase Therapeutics Inc IKT shares are trading higher by 31.1% to $1.56 during Wednesday’s session after the company announced the pricing of an approximately $110 million private placement financing.
What Else: Inhibikase says…